CompletedPhase 2NCT00057785
Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
Studying Squamous cell carcinoma of head and neck
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radiation Therapy Oncology Group
- Principal Investigator
- Nancy Lee, MDMemorial Sloan Kettering Cancer Center
- Intervention
- cisplatin(drug)
- Enrollment
- 68 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2003 – 2016
Study locations (17)
- Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States
- University of California Davis Cancer Center, Davis, California, United States
- Radiological Associates of Sacramento Medical Group, Incorporated, Sacramento, California, United States
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- Northeast Georgia Medical Center, Gainesville, Georgia, United States
- Mayo Clinic Cancer Center, Rochester, Minnesota, United States
- Siteman Cancer Center at Barnes-Jewish Hospital, St Louis, Missouri, United States
- Monmouth Medical Center, Long Branch, New Jersey, United States
- Albuquerque Regional Medical Center at Lovelace Sandia Health System, Albuquerque, New Mexico, United States
- Akron City Hospital, Akron, Ohio, United States
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
- Fox Chase-Temple Cancer Center, Philadelphia, Pennsylvania, United States
- CCOP - MainLine Health, Wynnewood, Pennsylvania, United States
- M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
- Wilford Hall Medical Center, Lackland Air Force Base, Texas, United States
- +2 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00057785 on ClinicalTrials.govOther trials for Squamous cell carcinoma of head and neck
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07333274Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaShandong Cancer Hospital and Institute
- RECRUITINGPHASE1NCT07182149A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsNormunity AccelCo, Inc.
- RECRUITINGPHASE3NCT07026474Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCUniversität des Saarlandes
- RECRUITINGNANCT07203911Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled TrialTobias Todsen
- RECRUITINGNANCT07180901Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck CancerCentre hospitalier de l'Université de Montréal (CHUM)
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07435415Local Injection Methylene Blue Combined With Radiation in HNSCC PatientsChina Medical University Hospital
- RECRUITINGPHASE2NCT07088211Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGPHASE2NCT07040956A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.West China Hospital
See all trials for Squamous cell carcinoma of head and neck →